Beta Bionics Inc
Beta Bionics Inc (BBNX) Historical Volatility
BBNX 30-day historical volatility is 80%. This ranks in the 70th percentile of readings over the past year.
Read more
Tracking BBNX historical volatility helps you see how much Beta Bionics Inc's stock price has actually moved over past periods, giving you a baseline to judge whether current option premiums are fair, cheap, or expensive. While implied volatility tells you what the market expects, Beta Bionics Inc's HV tells you what really happened. Use our scanner to monitor BBNX 30 day historical volatility alongside longer lookback windows and spot the moments when realized and implied diverge.
Historical volatility is the annualized standard deviation of an underlying's past returns, typically measured over rolling windows like 10, 20, 30, or 60 days. The BBNX 30 day historical volatility is one of the most widely watched readings because it balances responsiveness with stability. Comparing Beta Bionics Inc's HV to its implied volatility reveals the volatility risk premium — when IV sits well above HV, option sellers tend to have an edge; when HV runs hot relative to IV, buyers may be underpaying for movement.
Beta Bionics, Inc., a commercial-stage medical device company, engages in the design, development, and commercialization of solutions to enhance the health and quality of life of insulin-requiring people with diabetes. It offers iLet Bionic Pancreas, an insulin delivery device for the treatment of type 1 diabetes in adults and children six years of age and older. The company is also developing Patch Pump, an insulin pump that is designed to adhere directly to the skin and administer insulin without the need for tubing; Bihormonal iLet, which combines automated delivery of insulin and glucagon; and iLet to treat people with insulin-dependent type-2 diabetes.
It has collaboration and license agreement with Xeris Pharmaceuticals, Inc. (Xeris) to develop and commercialize a pump-compatible glucagon formulation; and development and commercialization agreement with Abbott Diabetes Care Inc. to develop and commercialize an automated insulin delivery system. The company was incorporated in 2015 and is based in Irvine, California.
Sizing a long premium trade, modeling a covered call, or hunting volatility arbitrage all come back to one question: how much has the stock actually moved? Our scanner puts Beta Bionics Inc's historical volatility side-by-side with implied readings across every lookback window, so you can see exactly where BBNX HV is running hot, cold, or in line. Make the BBNX 30 day historical volatility — and every other window — work for your edge instead of against it.
As of September 25, 2026
As of September 25, 2026
See how volatility has moved over time
Track BBNX historical volatility, spot where IV and realized volatility diverge, and find options that are priced in your favor right now.
Start your 14-day free trial→